Publication: The tick-derived rBmTI-A protease inhibitor attenuates the histological and functional changes induced by cigarette smoke exposure
Authors
Lourenço, Juliana D. ; Ito, Juliana T. ; Cervilha, Daniela A.B. ; Sales, Davi S. ; Riani, Alyne ; Suehiro, Camila L. ; Genaro, Isabella S. ; Duran, Adriana ; Puzer, Luciano ; Martins, Milton A. ; Sasaki, Sérgio D. ; Lopes, Fernanda D.T.Q.S.
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia. Departamento de Biología Celular e Histología
publication.page.editor
publication.page.department
DOI
DOI: 10.14670/HH-11-927
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Introduction. Smoking is the main risk
factor for chronic obstructive pulmonary disease
development and cigarette smoke (CS) exposure is
considered an important approach to reproduce in
rodents this human disease. We have previously shown
that in an elastase-induced model of emphysema, the
administration of a protease inhibitor (rBmTI-A)
prevented and attenuated tissue destruction in mice.
Thus, in this study we aimed to verify the effects of
rBmTI-A administration on the physiopathological
mechanisms of CS-induced emphysema. Methods. Mice
(C57BL/6) were exposed to CS or room air for 12
weeks. In this period, 3 nasal instillations of rBmTI-A
inhibitor or its vehicle were performed. After euthanasia,
respiratory mechanics were evaluated and lungs
removed for analysis of mean linear intercept, volume
proportion of collagen and elastic fibers, density of
polymorphonuclear cells, macrophages, and density of
positive cells for MMP-12, MMP-9, TIMP-1 and
gp91phox. Results. The rBmTI-A administration
improved tissue elastance, decreased alveolar
enlargement and collagen fibers accumulation to control
levels and attenuated elastic fibers accumulation in
animals exposed to CS. There was an increase of MMP12, MMP-9 and macrophages in CS groups and the
rBmTIA only decreased the number of MMP-12 positive
cells. Also, we demonstrated an increase in gp91phox in
CS treated group and in TIMP-1 levels in both rBmTI-A
treated groups. Conclusion. In summary, the rBmTI-A
administration attenuated emphysema development by
an increase of gp91phox and TIMP-1, accompanied by a
decrease in MMP-12 levels.
publication.page.subject
Citation
Histology and Histopathology, Vol.33, nº3, (2018)
item.page.embargo
Ir a Estadísticas
Este ítem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/